The business of human embryonic stem cell research and an international analysis of relevant laws

Journal of Biolaw and Business

Volumn 7, Issue 4, 2004, Pages 14-22

  De Trizio, Ella ^a   Brennan, Christopher S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELL DIFFERENTIATION; ECONOMIC ASPECT; EMBRYONIC STEM CELL; ENVIRONMENTAL ASPECTS AND RELATED PHENOMENA; GEOGRAPHIC DISTRIBUTION; HUMAN; LAW; NORTH AMERICA; REVIEW; ARTICLE; ASIA; AUSTRALIA; BIOMEDICAL AND BEHAVIORAL RESEARCH; CYTOLOGY; ECONOMICS; EMBRYO; EMBRYO RESEARCH; EUROPE; FINANCIAL MANAGEMENT; GENETICS AND REPRODUCTION; INTERNATIONAL COOPERATION; LEGAL APPROACH; LEGAL ASPECT; ORGANIZATION AND MANAGEMENT; POLICY; STEM CELL;

BIOMEDICAL AND BEHAVIORAL RESEARCH; GENETICS AND REPRODUCTION; LEGAL APPROACH;

ASIA; AUSTRALIA; EMBRYO; EMBRYO RESEARCH; EUROPE; FINANCING, GOVERNMENT; HUMANS; INTERNATIONALITY; NORTH AMERICA; PRIVATE SECTOR; PUBLIC POLICY; RESEARCH SUPPORT; STEM CELLS;

EID: 13844320040     PISSN: 10955127     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (117)

1. See Rick Weiss, Mature Human Embryos Cloned: South Koreans' Work Has Medical Promise but Raises Concerns, Wash. Post, Feb. 12, 2004, at A0 1.
2. See Andrew Scott, EU in Stem Cell Limbo: Council Meeting to Resolve the ES Cell Debate Fails to Reach a Decision, The Scientist, Dec. 4, 200 3.
3. See 〈http://www.cnn.com/2004/HEALTH/05/09/reagan.stem.ap/index. html〉 .
4. See 〈http://www.cnn.com/HEALTH/9811/03/stem.cell.discovery/ html〉.
5. See generally Part II infra.
6. See generally Part II infra.
7. See generally Part II infra.
8. See generally Cynthia Robbins-Roth, From Alchemy to IPO: The Business of Biotechnology 91-93 (Perseus Publishing 2001).
9. Id.
10. See Staff Writer, Fortune, Nov. 25, 2002 at 135.
11. See R.D. Burck (Chancellor of the University of Texas), Federal Research and Development Overview, Nov. 14, 2001 at 3 (statistics paper on file with authors).
12. See Luke Timmerman, Stem-Cell Research Still an Embryonic Business, The Seattle Times (Business & Tech. Section), Feb. 22, 2004.
13. See generally Part II infra.
14. See Audrey R. Chapman, Ph.D., et. al., Stem Cell Research and Applications: Monitoring the Frontiers of Biomedical Research, at 1, November 1999 (paper on file with authors).
15. Id.
16. See supra note 4 and accompanying text.
17. See 〈http://www.stemcellresearchfoundation.org/About/FAQ.htm〉.
18. Id.
19. See Dr. Mugur A. Roz, M.D., Ph.D., Stem Cells in Biomedicine ... With a Flavor of Bioethics (presentation available at 〈http://free.hostdepartment. com/ s/stem_cells/〉.
20. See 〈http://www.stemcellresearchfoundation.org/About/FAQ.htm〉.
21. See Sylvia Pag?n Westphal, Greater Potential of Adult Stem Cells Revealed, The New Scientist, May 17, 2003.
22. See id.
23. See, e.g., Maggie Fox, Cloned Cells Repair Mouse Hearts, U.S. Company Says, The World Health Network, Mar. 2004 available at 〈http://www. worldhealth.net/p/416,5374.html〉.
24. See Scott Gottlieb, Adult Cells Do It Better: Venture Capital Says Adult, Not Embryo, Stem Cells Are the Cure, The American Spectator, June 2001.
25. See 〈http//www.bizjournals.com/Pittsburgh/stories/2002/12/16/story2. html?page=3〉.
26. See Gottlieb, supra note 24.
27. See 〈http://www.viacellinc.com/index.asp?p=3〉.
28. See, e.g., 〈http://www.parentsguidecordblood.com/index.html〉.
29. See 〈http://www.isscr.org〉.
30. Id.
31. See Mary Niederberger, An Experimental Treatment Still in Its Infancy, Post-Gazette (Pittsburgh, PA), May 19, 1998.
32. Id.
33. Id.
34. See Helen Pearson, Cord Blood Claims Questioned, Nature, Feb. 5, 2003.
35. See 〈http://www.whitehouse.gov/news/releases/2001/08/print/20010809- 1. html〉.
36. See Dr. Mugur A. Roz, M.D., Ph.D., Stem Cells in Biomedicine ... With a Flavor of Bioethics (presentation available at 〈http://free.hostdepartment. com/ s/stem_cells/〉.
37. Nat'l Bioethics Advisory Comm'n., Ethical Issues In Human Stem Cell Research: Volume I: Report and Recommendations of the National Bioethics Advisory Commission 9-10 (1999) (available at 〈http://www. georgetown.edu/research/nrcbl/nbac/stemcell.pdf〉).
38. See Roz, supra note 36.
39. See Howard Markel, Weighing Medical Ethics for Many Years to Come, N.Y. Times, July 2, 2002, at F6.
40. See Rick Weiss, Mature Human Embryos Cloned: South Koreans' Work Has medical Promise but Raises Concerns, Wash. Post, Feb. 12, 2004, at A01.
41. Id.
42. See, e.g., Nat'l Acad. of Sciences, U.S. Policy-Makers Should Ban Reproductive Cloning, The National Academies, Jan. 2002.
43. Id.
44. See Paul Elias, America Lags in Stem Cell Research: Political Pressure Limits Funds for Cloning Experiments, The Associated Press, Feb. 13, 2004 (available at 〈http://www.msnbc.msn.com/id/4261823〉).
45. See 〈http//www.bizjournals.com/Pittsburgh/stories/2002/12/16/story2. html? page=3〉.
46. See Elias, supra note 44.
47. Id.
48. See Scott Gottlieb, Adult Cells Do It Better: Venture Capital Says Adult, Not Embryo, Stem Cells Are the Cure, The American Spectator, June 2001.
49. See Paul Mitchell, International Governments Hold Buck Stem Cell Research, International Committee of the Fourth International, Aug. 12, 2003.
50. See Send in the Clones, The Economist, Aug. 22, 2002.
51. Id.
52. See Richard Black, Singapore Hi-Tech Haven Opens, BBC News World Edition, Oct. 29, 2003.
53. See A*STAR Press Release, Biopolis Ready For Action: Singapore's Biomedical Hub Set to Open, Oct. 23, 2003, (available at 〈http://www.a- star.edu.sg/ astar/about/action/pressrelease_details.do?id=05f58ba5097Sn〉).
54. See Richard Black, Singapore Hi-Tech Haven Opens, BBC News World Edition, Oct. 29, 2003.
55. See A*STAR, supra note 53.
56. See Patrick Goodenough, Asian Pro-Lifers to Meet Amid Push for Embryonic Research, Cybercast News Service, Nov. 5, 2003 (available at 〈http://www.cnsnews.com〉).
57. See Dolly the Sheep Scientist Quits Scotland Over Lack of Venture Cash, Mar. 18, 2004 (available at 〈http:/www.ananova.com/business/story/ sm_540591. html〉).
58. Id.
59. See Send in the Clones, The Economist, Aug. 22, 2002.
60. Id.
61. See A*STAR Press Release, ViaCell, Inc. Announces Global Research and Development Operations with the Establishment of Singapore Research Centre, Feb. 5, 2002 (available at 〈http://www.biomed-singapore. com/bms/sg/en_uk/index/newsroom/pressrelease/2002/viacell〉).
62. See Barbara Demick, S. Korea a Hotbed of Cloning Research, L.A. Times, Feb. 22, 2004.
63. Id.
64. Id.
65. Id.
66. Id.
67. See Research Update, JDRF Plays Critical Role in International Stem Cell Debate, JDRF Website (available at 〈http://216.167.3.245/research/ features/res111302c.php〉).
68. See supra note 61 and accompanying text.
69. See Staff Writer, Embryo Stem Cell Research OK'd, The Japan Times, Feb. 14, 2004.
70. Id.
71. See Staff Writer, EU to fund Stem Cell Research Despite Split, Cell News, Dec. 3, 2003.
72. See Staff Writer, EU Split Over Stem Cell Research, BBC News, July 10,2003.
73. See Staff Writer, EU to Fund Stem Cell Research Despite Split, Cell News, Dec. 3, 2003.
74. Id.
75. Id.
76. See Stem Cell Research Regulations in the European Union, International Society for Stem Cell Research (updated Oct. 17, 2003) (available at 〈http//www.isscr.org/scientists/legislative.htm〉).
77. See Ned Stafford, Speech Stirs Stem Cell Debate, The Scientist, Nov. 7, 2003.
78. See Staff Writer, Stem Cell Bank Sparks Political Divisions in Spain, N.Y. Times, Feb. 15, 2004.
79. See Doug Payne, UK Presses Ahead with Stem Cell Research While Germany, Spain and the US Agonize Over Ethical Issues, The ELSO Gazette, Feb. 2003 (available at 〈http://www.the-elso-gazetter.org/magazine/issue13/-news/ news4.asp〉).
80. See Raja Mishra, US Stem Cell Support Lures US Scientist, The Morton Cure Paralysis Fund, Nov. 17,2002 (available at 〈http://www.nicpf.org/ disphyarticle. asp?articleld=81〉).
81. See supra note 79 and accompanying text.
82. Id.
83. Id.
84. Id.
85. See Mishra, supra note 80.
86. Id.
87. See Staff Writer, Sweden Stem Cell Success, Cell News, Oct. 19, 2002.
88. Id.
89. Id.
90. Id.
91. Id.
92. See Dan Lee, Sweden Forging Ahead on Stem Cells, The Mercury News, Mar. 30, 2003.
93. Id.
94. Id.
95. Id.
96. See Canadian Institutes of Health Research's March 2002 "Human Pluripotent Stem Cell Research Guidelines."
97. See Doug Payne, Canada Passes Cloning Law, The Scientist, Mar. 16, 2004.
98. Id.
99. See Bill C-6: An Act Respecting Assisted Human Reproduction and Related Research.
100. Id.
101. See Kristen Philipkoski, Canada Closes Door on Cloning, Wired News, Mar. 17, 2004.
102. See 〈http://www.whitehouse.gov/news/releases/2001/08/print/20010809- 1. html〉.
103. Id.
104. See Ted Agres, Senators Urge Stem Cell Expansion, The Scientist, Apr. 25, 2003.
105. See Merrill Goozner, US Stem Cell Researches Chafe, The Scientist, Dec. 5, 2003.
106. See Staff Writer, Harvard Planning Stem Cell Research Center, SiliconValley.com, Mar. 1, 2004.
107. See Chuck Nowlen, Stem Cell Research Gets Boost, The Capital Times, Mar. 8, 2004.
108. See Steve Mitchell, U.S. Stem Cell Policy Deters Investors, United Press International, Nov. 2, 2002.
109. See Editorial, California Plunges Forth In Mire of Stem-Cell Research, Tampa Trib., Sept. 28, 2002, at 20;
110. Laura Mansnerus, In Stem-Cell Law, Supporters See Opportunity for New Jersey, N.Y. Times, Jan. 6, 2004.
111. Laura Mansnerus, New Jersey Governor Puts Stem Cell Research in Budget Plan, N.Y. Times, Feb. 21, 2004.
112. Id.
113. See Welsey J. Smith, Clone the Taxpayers, Forbes, Mar. 15, 2004.
114. See Staff Writer, Stem-Cell Research's Creative Financing, The Stem Cell Network, Mar. 15, 2004.
115. See Steve Mitchell, U.S. Stem Cell Policy Deters Investors, United Press International, Nov. 2, 2002.
116. Id.
117. Id.